Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
29.06
+0.28 (0.97%)
At close: Mar 9, 2026, 4:00 PM EDT
29.64
+0.58 (2.00%)
After-hours: Mar 9, 2026, 6:38 PM EDT
Septerna Revenue
Septerna had revenue of $21.50M in the quarter ending September 30, 2025, with 12,113.07% growth. This brings the company's revenue in the last twelve months to $22.05M, up 2,147.20% year-over-year. In the year 2024, Septerna had annual revenue of $1.08M with 611.92% growth.
Revenue (ttm)
$22.05M
Revenue Growth
+2,147.20%
P/S Ratio
59.02
Revenue / Employee
$293,933
Employees
75
Market Cap
1.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.08M | 924.00K | 611.92% |
| Dec 31, 2023 | 151.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSEPN News
- 4 hours ago - Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 8 days ago - Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy - GlobeNewsWire
- 13 days ago - Septerna to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 27 days ago - Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting - GlobeNewsWire
- 2 months ago - Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer - GlobeNewsWire
- 2 months ago - Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Septerna to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewsWire